Exxon Mobil and LyondellBasell are reportedly among the bidders for Shell’s U.S. chemicals portfolio

Shell is exploring a sale of its U.S. chemicals assets, and a report from Financial Times indicates that Exxon Mobil and LyondellBasell have drawn interest as possible bidders, according to coverage carried by Yahoo Finance. The assets under discussion are described as potentially worth as much as $8 billion, as Shell looks for ways to pare back and refocus parts of its downstream chemicals footprint.

The reported process, as described in the market coverage, centers on identifying buyers for specific U.S. chemicals holdings rather than a broad exit of chemicals altogether. For Exxon Mobil and LyondellBasell, the attraction of such assets would be their position in the U.S. market and the opportunity to add scale in a segment that is often closely tied to demand for industrial inputs.

For Shell, chemicals have historically been both a strategic buffer against weaker refining margins and a contributor to cash generation, but they also require capital-intensive operations and face cyclical demand. In that context, selling a sizable U.S. portfolio would be consistent with efforts to reduce complexity and redeploy capital toward other areas of the business, a theme that appears in many large energy majors’ portfolio reviews.

Exxon Mobil, known primarily for oil and gas production, has also maintained a chemicals presence through its integrated value chain and downstream operations. LyondellBasell, meanwhile, is one of the world’s larger plastics and chemicals producers, and acquisitions are a common pathway for expanding product capacity and market share.

Neither Exxon Mobil nor LyondellBasell, as reflected in the published market post, provided deal-specific comments. The report characterizes the companies as “possible bidders,” which leaves open whether they have submitted offers, whether their bids are competing against others, and what portions of the portfolio would be included in any final transaction.

What is not stated in the coverage is as important as what is. The market post does not specify which particular chemicals sites, product lines, or legal entities would be included in the proposed sale, nor does it describe expected timing, financing terms, or whether the $8 billion figure represents an enterprise value target, an equity value range, or an indicative valuation discussed in preliminary discussions.

It also remains unclear whether Shell intends a full divestment of its U.S. chemicals unit or a partial sale, or how any remaining operations would be affected operationally and contractually. Buyers in chemicals deals often depend on long-term supply and offtake contracts, utilities arrangements, and integration opportunities, but none of that detail is provided in the cited market coverage.

Going forward, the main items to watch would be whether Shell confirms a formal sale process, whether additional bidders surface, and whether the reported valuation translates into a binding offer or a narrower set of assets than initially described. Any subsequent disclosures, such as regulatory filings or company statements, would also help clarify the scope of the portfolio and the likely structure of the transaction.